mRNA |
NSC95397 |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.04 |
mRNA |
CHM-1 |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.04 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.05 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.05 |
mRNA |
GW843682X |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.06 |
mRNA |
Ko-143 |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.06 |
mRNA |
MS-275 |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.07 |
mRNA |
C6-ceramide |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.07 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.07 |
mRNA |
BMS-345541 |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.07 |